Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 31  |  Issue : 2  |  Page : 487-493

Primary assessment of radiofrequency ablation combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma, a comparative study with traditional transarterial chemoembolization


1 Department of Radiology, Faculty of Medicine, Menoufiya University, Shibin Al Kawm, Egypt
2 Department of Radiology, National Liver Institute, Menoufiya University, Shibin Al Kawm, Egypt

Correspondence Address:
Mohamed K Abd El-Mageed
Radiology Department, Faculty of Medicine, Menoufia University, Shibin Al Kawm
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.239720

Rights and Permissions

Objectives This study aimed to evaluate the role and efficacy of combined transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) in the management of patients with large unresectable hepatocellular carcinoma (HCC) in comparison with traditional TACE alone. Background Surgery is still the treatment of choice for patients with HCC when diagnosed at an early stage. Unfortunately, most HCCs are diagnosed at intermediate or advanced stages. RFA is an alternative to partial hepatectomy for early HCC less than 3 cm. TACE is classified as palliative therapy in patients with intermediate-stage HCC. However, neither TACE nor RFA can result in adequate control of large-sized HCCs. Sequential application of TACE and RFA is increasingly being used in the treatment of medium-sized or large-sized HCC to overcome the limitations of each technique. Patients and methods This prospective study included 40 patients (men/women ratio: 31/9) who had a large unresectable HCC (<5 cm in maximum diameter). Patients were divided into two groups: the first group was treated with combined therapy (TACE–RFA) whereas the second group was treated with traditional TACE. Finally, the therapeutic response was evaluated by 1-month postprocedure triphasic computed tomography. Results The 1-month postprocedure triphasic computed tomography indicated that a complete response was achieved in 19/20 patients in group I and 8/20 patients in group II, whereas a partial response was achieved in 1/20 patients in group I and 10/20 patients in group II. A stable disease was observed in 2/20 patients in group II alone. Finally, no evidence of disease progression could be observed in both groups. Conclusion Combined therapy TACE–RFA is superior to TACE alone in achieving better therapeutic effects for patients with large unresectable HCC.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed120    
    Printed0    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal